Sign in to continue:

Thursday, January 29th, 2026

Niks Professional Ltd. Receives SGX Approval for Delisting via Selective Capital Reduction – Key Dates and Shareholder Information

Niks Professional Ltd. – Key Developments on Proposed Delisting and Selective Capital Reduction

Niks Professional Ltd. Announces Key Milestones Towards Delisting from SGX Catalist Board

Summary

Niks Professional Ltd. (“the Company”) has provided a comprehensive update regarding its proposed selective capital reduction exercise and imminent delisting from the Singapore Exchange Securities Trading Limited (SGX-ST) Catalist Board. The company has successfully cleared several critical regulatory and procedural hurdles, indicating significant changes for shareholders and potentially impacting the share value.

Key Points for Investors

  • Delisting Approval Granted: SGX-ST has granted approval for the Company’s proposed delisting, effective 9.00 a.m. (Singapore time) on 22 January 2026. This major development will see Niks Professional Ltd. cease trading on the Catalist Board, which may significantly affect liquidity and future share value.
  • Selective Capital Reduction Exercise: The Company is implementing a selective capital reduction, involving a cash distribution to eligible shareholders. Payment is scheduled for on or around 19 January 2026. This provides a direct monetary return to shareholders, but also means the shares will be cancelled as a result of the reduction.
  • Completion Conditions: The delisting is subject to three main conditions:
    • Completion of the cash distribution to eligible shareholders.
    • Immediate announcement of the delisting approval (already completed).
    • Submission of written confirmation to SGX-ST that the Company is not aware of any material information affecting investors’ decision that has not yet been announced (already completed).
  • Trading Suspension: Trading of the Company’s shares has been suspended since 29 December 2025 in preparation for the capital reduction and delisting process. Investors should note that trading will not resume prior to delisting.
  • Legal and Regulatory Compliance: The Company has received court approval for the capital reduction and has disclosed all relevant proceedings and shareholder communications, indicating strict compliance with regulatory requirements.

Important Information for Shareholders

  • Monetary Impact: Eligible shareholders will receive a cash distribution as part of the selective capital reduction. The specifics of the amount and eligibility criteria are detailed in prior circulars and announcements. Shareholders should review these to confirm their entitlement.
  • Share Cancellation: Shares subject to the capital reduction will be cancelled, and shareholders will no longer have equity interest in the Company post-delisting, except as provided in the terms of the reduction.
  • Final Trading Dates: Since trading was suspended on 29 December 2025, investors have lost the ability to buy or sell shares on the open market. The delisting on 22 January 2026 finalizes this process.
  • Disclosure and Responsibility: The Company and Non-Participating Shareholders have affirmed that all material facts have been disclosed and that no information which could materially affect investors’ decisions has been withheld.
  • Future Updates: Further announcements will be made if there are any changes or developments in the process, especially if there are delays or amendments to the capital reduction or delisting schedule.

Potential Price Sensitivity and Market Impact

  • The imminent delisting constitutes a significant event that will affect share value, liquidity, and the ability of shareholders to trade their shares. Typically, such corporate actions can cause volatility in share price leading up to suspension, and may result in a price impact if/when secondary market trading is possible (such as off-market transactions).
  • Cash distribution provides a partial exit for eligible shareholders, but those not participating may be affected by the loss of market access and the cancellation of shares.
  • The Company has affirmed there are no undisclosed material facts that would affect investor decisions, reducing the risk of unexpected price-moving disclosures.

Contact Information

For further queries, investors can contact the Company’s sponsor, SAC Capital Private Limited (Ms Charmian Lim, Tel: (65) 6232 3210) at 1 Robinson Road, #21-01 AIA Tower, Singapore 048542.

Disclaimer

This article is prepared for informational purposes only and does not constitute investment advice or an offer to buy or sell any securities. Investors should consult their financial advisors and refer to official company announcements and circulars for detailed terms and conditions. Neither the Company nor its sponsor nor the author of this article assumes any responsibility for investment decisions made based on this information.


View Niks Prof Historical chart here



GKE Corporation Receives SGX Approval for Placement of 88 Million New Shares at S$0.0968 Each 1

GKE Corporation’s S\$8.5 Million Share Placement Receives SGX Green Light: What Investors Must Know GKE Corporation’s S\$8.5 Million Share Placement Receives SGX Green Light: What Investors Must Know Key Highlights from GKE Corporation Limited’s...

iX Biopharma Upsizes Share Placement to S$6.7 Million to Fund US Expansion, Equipment Purchase, and Debt Repayment

iX Biopharma Upsizes Placement: S\$6.7M Raised for US Expansion, Debt Repayment & Growth iX Biopharma Upsizes Placement: S\$6.7 Million Raised to Fuel US Expansion, Equipment Investment, and Debt Repayment Key Highlights from iX Biopharma’s...

Ever Glory United Holdings Limited Announces Receipt of Listing and Quotation Notice for Bonus Issue and Convertible Bonds

Key Points: The Company has received a LQN from the SGX-ST for the listing and quotation of up to 86,635,783 Bonus Shares. The Company has also received a LQN for the listing and quotation...